The association between HIV (treatment), pregnancy serum lipid concentrations and pregnancy outcomes: a systematic review

Abstract

BackgroundObserved adverse effects of antiretroviral therapy (ART) on the lipid profile could be of significance in pregnancy. This systematic review aims to summarize studies that investigated the association between HIV, ART and serum lipids during pregnancy and adverse pregnancy outcomes.MethodsA systematic search was conducted in five electronic databases to obtain articles that measured serum lipid concentrations or the incidence of dyslipidaemia in HIV-infected pregnant women. Included articles were assessed for quality according to the Cochrane Risk of Bias Tool. The extracted data was analysed through descriptive analysis.ResultsOf the 1264 articles screened, 17 articles were included in this review; eleven reported the incidence of dyslipidaemia, and twelve on maternal serum lipid concentrations under the influence of HIV-infection and ART. No articles reported pregnancy outcomes in relation to serum lipids. Articles were of acceptable quality, but heterogenic in methods and study design. Lipid levels in HIV-infected women increased 1.5–3 fold over the trimesters of pregnancy, and remained within the physiological reference range. The percentage of women with dyslipidaemia was variable between the studies [0–88.9%] and highest in the groups on first generation protease inhibitors and for women on ART at conception.ConclusionThis systematic review observed physiologic concentrations of serum lipids for HIV-infected women receiving ART during pregnancy. Serum lipids were increased in users of first generation protease inhibitors and for those on treatment at conception. There was no information available about pregnancy outcomes. Future studies are needed which include HIV-uninfected control groups, control for potential confounders, and overcome limitations associated with included studies.Electronic supplementary materialThe online version of this article (doi:10.1186/s12879-017-2581-8) contains supplementary material, which is available to authorized users.

Epilepsy management in pregnant HIV+ women in sub-Saharan Africa, clinical aspects to consider: a scoping review

“…Pregnant WWE on EI-AEDs may be at higher risk of dyslipidemia with studies from HIC suggesting an association with carbamazepine use [ 74 – 78 ]. Similarly, HAART has been implicated in dyslipidemia [ 79 – 81 ] during pregnancy, and especially and PI intake [ 82 ].…”

Incidence and predictors of adverse pregnancy outcomes with maternal HIV-1 immune reconstitution inflammatory response syndrome among women within reproductive age in selected hospitals, Nairobi, Kenya (A prospective cohort study)

“…hypertensive disorder should be combined with other maternal characteristics, medical and obstetric history when calculating an individualized adjusted risk for adverse pregnancy complications. It was found that, hypertensive disorder increases the risk for stillbirth, PE, SGA, GDM, iatrogenic PTB and elective CS and reduces the risk for LGA (31). A study done in a facility based setting in China predicted adverse birth outcomes in a similar manner, precisely still birth which, the risk decreased as gestational age increased for all women and for all subtypes of hypertensive disorder and it was similar in hypertensive and normo-tensive women younger than 20 years of age.…”

Intracranial vascular complications in AIDS

“…Прослеживается взаимосвязь между АРВТ (ингибирующей протеазы) и сахарным диабетом. АРВТ токсически воздействует на стенку артерии, изменяя структуру ее липидов [1,[22][23][24][25][26][27][28].…”